Search General Info
Search Education
Search Partnering Companies
Speaker

Bassil Dahiyat

PRESIDENT AND CHIEF EXECUTIVE OFFICER, XENCOR
Monrovia , California, United States
Dr. Dahiyat has been Xencor’s president and chief executive officer since the Company’s incorporation in August 1997, and is the co-founder of Xencor, and co-inventor of Xencor’s breakthrough XmAb® technology. He has led the Company in raising over $700 million in public and private financing, creating a diverse portfolio of monoclonal antibody clinical programs for the treatment of life-threatening and debilitating diseases, and establishing alliances with leading biopharmaceutical companies that generated over $200 million in upfront payments. Dr. Dahiyat holds a Ph.D. in Chemistry from Caltech and B.S. and M.S.E. degrees in Biomedical Engineering from the Johns Hopkins University. He has co-authored numerous scientific papers in the fields of protein design and drug delivery, is an inventor of over 30 US and numerous foreign patents, and has received scientific awards from the American Chemical Society, the Controlled Release Society, the Protein Society and Caltech.
Speaking In
10:00 AM - 10:55 AM
Thursday, June 11
Since the first FDA approved bispecific antibody Blincyto hit the market in 2015, a wave of new…
Track Blue (Pacific Time zone listed start time)